Literature DB >> 9308551

High rate of malignant transformation in hyperkeratotic actinic keratoses.

J M Suchniak1, S Baer, L H Goldberg.   

Abstract

BACKGROUND: Controversy exists over the rate of malignant transformation of actinic keratoses (AKs) and, therefore, which treatment is indicated. Furthermore, it is not known to what degree each of the separate clinical subtypes of AKs become malignant.
OBJECTIVE: Our purpose was to examine clinically diagnosed hyperkeratotic AKs and classify them histologically.
METHODS: Fifty papular hyperkeratotic AKs on the dorsum of the hand, wrist, and arm, less than 1 cm in diameter, were identified in 43 patients. Histologic evaluation was conducted in a blinded fashion by two observers.
RESULTS: Histologic examination showed 18 lesions (36%) to be invasive squamous cell carcinoma, whereas another seven (14%) were squamous cell carcinoma in situ. Proliferative AKs were the next most common lesion identified (26%), followed by hypertrophic (10%) and lichenoid (4%) AKs. Basal cell carcinomas (4%) and other benign lesions (6%) comprised the rest of the biopsy specimens.
CONCLUSION: It is possible to predict clinically, with greater certainty than previously realized, which AKs have a greater tendency toward malignant change. Clinical hyperkeratotic AKs less than 1 cm in diameter on the dorsum of the hand, wrist, or forearms of white patients have a malignancy rate of 50%. Lesions with this clinical description should be removed by shave biopsy, then by 35% trichloroacetic acid, then liquid nitrogen to a width and depth of 3 mm.

Entities:  

Mesh:

Year:  1997        PMID: 9308551     DOI: 10.1016/s0190-9622(97)70137-3

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  7 in total

1.  Early-life or lifetime sun exposure, sun reaction, and the risk of squamous cell carcinoma in an Asian population.

Authors:  Yen-Ching Chen; David C Christiani; Huey-Jen Jenny Su; Yu-Mei Hsueh; Thomas J Smith; Louise M Ryan; Sheau-Chiou Chao; Julia Yu-Yun Lee; Yue-Liang Leon Guo
Journal:  Cancer Causes Control       Date:  2010-01-19       Impact factor: 2.506

2.  Potential risk factors for cutaneous squamous cell carcinoma include oral contraceptives: results of a nested case-control study.

Authors:  Maryam M Asgari; Jimmy T Efird; E Margaret Warton; Gary D Friedman
Journal:  Int J Environ Res Public Health       Date:  2010-02-03       Impact factor: 3.390

3.  High risk cutaneous squamous cell carcinoma of the head and neck.

Authors:  Stephen Y Kang; Amanda E Toland
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2016-08-01

4.  Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial.

Authors:  Eggert Stockfleth; Ralph von Kiedrowski; Rolf Dominicus; John Ryan; Adam Ellery; Meritxell Falqués; Nathalie Ivanoff; Rosario Rodriguez Azeredo
Journal:  Dermatol Ther (Heidelb)       Date:  2016-12-19

Review 5.  Clinical Characteristics of Actinic Keratosis Associated with the Risk of Progression to Invasive Squamous Cell Carcinoma: A Systematic Review.

Authors:  Alise Balcere; Laura Konrāde-Jilmaza; Laura Agnese Pauliņa; Ingrīda Čēma; Angelika Krūmiņa
Journal:  J Clin Med       Date:  2022-10-06       Impact factor: 4.964

6.  Uncommon Presentation of Metastatic Squamous Cell Carcinoma of the Skin and Treatment Challenges.

Authors:  Anita Pandey; Maksim Liaukovich; Kishor Joshi; Boris I Avezbakiyev; James E O'Donnell
Journal:  Am J Case Rep       Date:  2019-03-06

Review 7.  A review of actinic keratosis, skin field cancerisation and the efficacy of topical therapies.

Authors:  Robert Sinclair; Christopher Baker; Lynda Spelman; Madeleine Supranowicz; Beth MacMahon
Journal:  Australas J Dermatol       Date:  2020-08-25       Impact factor: 2.875

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.